If you're a smoker who's trying to quit, you may recall hearing about vaccines designed to cause the body's immune system to treat nicotine like a foreign invader, producing antibodies that trap and remove it before it's able to reach receptors in the brain. It's a fascinating idea, but according to scientists at California's Scripps Research Institute, a recent high-profile attempt had a major flaw. They claim to have overcome that problem, and are now developing a vaccine of their own that they believe should be more effective. .. Continue Reading New nicotine vaccine may succeed at treating smoking addiction, where others have failed
Section: Health and Wellbeing
Tags: Addiction, American Chemical Society, Brain, Scripps Research Institute, Smoking, Tobacco, Vaccines
Related Articles:
- New vaccine could provide lifetime immunity to nicotine addiction
- Researchers create vaccine against heroin high
- Methamphetamine vaccine shows promise
- Immune system discovery could lead to a vaccine for heart disease
- Spanish scientists trial promising HIV vaccine
- Scientists discover antibodies that neutralize over 91 percent of HIV strains